THURSDAY, Dec. 19, 2024 (HealthDay News) — The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over. Tirzepatide includes blockbuster injected GLP-1 medications Mounjaro (for diabetes) and Zepbound (for weight loss). The FDA firstContinue Reading

THURSDAY, Dec. 19, 2024 (HealthDay News) — It’s a perhaps unexpected consequence of climate change that periods of deep cold now occur more frequently during American winters, despite an overall trend to warmer temperatures year round. That uptick in cold snaps, along with other possible factors, has been linked toContinue Reading

THURSDAY, Dec. 19, 2024 (HealthDay News) — The U.S. Department of Justice (DOJ) has filed a civil complaint against CVS Pharmacy Inc., accusing the nation’s largest pharmacy chain of unlawfully filling prescriptions for highly addictive opioids and violating federal health care laws. According to a news release published Dec. 18,Continue Reading

THURSDAY, Dec. 19, 2024 (HealthDay News) — Sleep apnea is known to wreak havoc with the body, contributing to heart problems, diabetes and liver disease. The sleep disorder also appears to have direct effects on brain health, a new study shows. People with sleep apnea appear to experience accelerated agingContinue Reading